The National Agency for Food and Drug Administration and Control (NAFDAC) has raised a public health alert over the circulation ...

The US Food and Drug Administration (FDA) has approved the belimumab 200 mg/mL autoinjector for children aged 5 years of older with active lupus nephritis (LN) who are receiving standard therapy.

The U.S. Food & Drug Administration (FDA) has granted approval for a new subcutaneous autoinjector formulation of belimumab ...

For $45 million upfront, Vor Bio is gaining ex-China rights to RemeGen’s telitacicept, a first-in-class recombinant ...

Benlysta is supplied as a single-dose prefilled autoinjector or prefilled syringe containing 200mg/mL of belimumab for SC use. The prefilled syringe has not been studied in pediatric patients aged ...

Nektar, which accused Lilly of making errors in its analysis of the data, forged ahead with the programme and started the ...

DelveInsight’s, “Systemic Mastocytosis Pipeline Insight, 2025,” report provides comprehensive insights about 8+ companies and ...

The first six minutes of the flight to Southern California’s Ontario International Airport were routine. The Boeing 737 Max 9 ...

Former Venezuelan military intelligence chief Hugo Carvajal has reached an agreement to plead guilty to federal drug ...

Only five days after FDA approval of Yutrepia, Liquidia announced its first commercial shipment of the therapy, making prescriptions available to patients at specialty pharmacies. “We have moved with ...

Mr. Jon E. RiceActing DirectorOffice of National Drug Control PolicyExecutive Office of the President Washington, D.C. 20503 RE: 2026 National Drug Control Strategy Dear Mr. Rice: The R Street ...

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the initiation of two new clinical trials to investigate the efficacy and safety of nemolizumab in treating patients ...